Carmen Martín-Gómez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Carmen Martín-Gómez has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Emma Motrico
Department of Developmental and Educational Psychology, School of Psychology, University of Seville, Seville, Spain
3 shared publications Juan Antonio Blasco-Amaro
Andalusian Health Technology Assessment Area (AETSA), Andalusian Public Foundation Progress and Health, Junta de Andalucia, Seville, Spain
3 shared publications- André Bernard Rietman
Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC Sophia Children’s Hospital, Rotterdam, the Netherlands
2 shared publications - Anne-Mette Brendahl
Norwegian Centre for Rare Diseases, Unit Sunnaas, Sunnaas Rehabilitation Hospital, Bjørnemyr, Norway
2 shared publications - Caterina Grano
Department of Psychology, Sapienza University of Rome, Via dei Marsi, 78, 00185 Rome, Italy
2 shared publications - Diana Kwast Hoekstra2 shared publications
Latest Publications
- 1 April 2026
- Published by EURORDIS-Rare Diseases Europe
The Psychological Needs of People living with a Rare Condition
In this literature review conducted by EURORDIS, we examine the psychological and psychosocial needs of people living with a rare condition and their families. The findings highlight that people living with a rare condition and their families face common and persistent challenges. These include chronic uncertainty, limited access to reliable information, stigma, social isolation, and difficulties navigating fragmented healthcare systems. Many individuals and caregivers also take on the role of coordinating care themselves, often without adequate support. The report emphasises that psychological needs evolve over time, particularly at key stages such as diagnosis, disease progression, and transition to adult care. Despite this, psychological and psychosocial support remains a major unmet need across the rare disease community. In response, the report calls for more integrated, family-centred and multidisciplinary care, with psychological support embedded throughout the care pathway and stronger links with patient organisations to better support individuals and families.
- 1 April 2026
- Published by EURORDIS-Rare Diseases Europe
The Psychological Needs of People living with a Rare Condition
In this literature review conducted by EURORDIS, we examine the psychological and psychosocial needs of people living with a rare condition and their families. The findings highlight that people living with a rare condition and their families face common and persistent challenges. These include chronic uncertainty, limited access to reliable information, stigma, social isolation, and difficulties navigating fragmented healthcare systems. Many individuals and caregivers also take on the role of coordinating care themselves, often without adequate support. The report emphasises that psychological needs evolve over time, particularly at key stages such as diagnosis, disease progression, and transition to adult care. Despite this, psychological and psychosocial support remains a major unmet need across the rare disease community. In response, the report calls for more integrated, family-centred and multidisciplinary care, with psychological support embedded throughout the care pathway and stronger links with patient organisations to better support individuals and families.
- 1 April 2026
- Published by EURORDIS-Rare Diseases Europe
EURORDIS Paper: Importance of Psychological Support for Living Well with a Rare Condition
In this EURORDIS paper, we explore the importance of psychological support to live will with a rare disease. The literature review highlights the importance of integrating psychological and psychosocial support into rare disease care pathways, particularly at key stages such as diagnosis and disease progression, when emotional distress and uncertainty are often highest. The findings demonstrate that family-centred and community-based approaches improve wellbeing. Interventions that strengthen coping strategies, such as acceptance, resilience, and self-efficacy, are associated with better mental health outcomes and quality of life. Access to peer support, social networks, and clear, reliable information also plays a key role in helping individuals and families manage the challenges of living with a rare condition. The paper calls for more holistic, multidisciplinary and psychologically informed care models, with psychological support embedded throughout care pathways. It also calls for stronger policy action to address gaps in provision and ensure equitable access to mental health and psychosocial support across rare disease systems.
- 1 April 2026
- Published by EURORDIS-Rare Diseases Europe
EURORDIS Paper: Importance of Psychological Support for Living Well with a Rare Condition
In this EURORDIS paper, we explore the importance of psychological support to live will with a rare disease. The literature review highlights the importance of integrating psychological and psychosocial support into rare disease care pathways, particularly at key stages such as diagnosis and disease progression, when emotional distress and uncertainty are often highest. The findings demonstrate that family-centred and community-based approaches improve wellbeing. Interventions that strengthen coping strategies, such as acceptance, resilience, and self-efficacy, are associated with better mental health outcomes and quality of life. Access to peer support, social networks, and clear, reliable information also plays a key role in helping individuals and families manage the challenges of living with a rare condition. The paper calls for more holistic, multidisciplinary and psychologically informed care models, with psychological support embedded throughout care pathways. It also calls for stronger policy action to address gaps in provision and ensure equitable access to mental health and psychosocial support across rare disease systems.
- Open Access
- 19 February 2025
- Published by Elsevier in Patient Education and Counseling
- Vol. 135, 108708
A proposal to involve people living with rare and complex conditions in the development of clinical practice guidelines
- 19 February 2025
- Published by Elsevier in Patient Education and Counseling
- Vol. 135, 108708
Open AccessA proposal to involve people living with rare and complex conditions in the development of clinical practice guidelines
- Open Access
- 13 January 2025
- Published by Wiley in New Directions for Child and Adolescent Development
- Vol. 2025 (1)
The Developmental Assets Model for Positive Youth Development and Social Contribution: A Qualitative Study of Spanish Undergraduates
Relational developmental systems theory integrates a positive youth development (PYD) perspective on the transition to adulthood. Meanwhile, the developmental assets (DAs) model describes the personal and contextual resources that nurture PYD. This study examined the fulfillment of DAs and experience of social contribution in a sample of 23 Spanish undergraduates from seven universities (age range 18–25, M age = 20.57, SD = 2.06). Data were collected from seven focus groups, each comprising undergraduate students from different academic years, universities, and degree programs. All interviews were conducted in Spanish for 50–65 min and comprised eight questions divided into three sections (internal assets, external assets, and social contribution and barriers). The results indicated that among internal assets, positive values, social competencies, and positive identity were important for adolescents. Additionally, the external asset of social support was a highly relevant resource. Regarding social contribution, the participants showed empathy towards the needs of the community and reported that helping others was rewarding. Clearly, the youth’s perspectives on their development should be considered while creating prevention and promotion programs that foster internal and external assets.
- 13 January 2025
- Published by Wiley in New Directions for Child and Adolescent Development
- Vol. 2025 (1)
Open AccessThe Developmental Assets Model for Positive Youth Development and Social Contribution: A Qualitative Study of Spanish Undergraduates
Relational developmental systems theory integrates a positive youth development (PYD) perspective on the transition to adulthood. Meanwhile, the developmental assets (DAs) model describes the personal and contextual resources that nurture PYD. This study examined the fulfillment of DAs and experience of social contribution in a sample of 23 Spanish undergraduates from seven universities (age range 18–25, M age = 20.57, SD = 2.06). Data were collected from seven focus groups, each comprising undergraduate students from different academic years, universities, and degree programs. All interviews were conducted in Spanish for 50–65 min and comprised eight questions divided into three sections (internal assets, external assets, and social contribution and barriers). The results indicated that among internal assets, positive values, social competencies, and positive identity were important for adolescents. Additionally, the external asset of social support was a highly relevant resource. Regarding social contribution, the participants showed empathy towards the needs of the community and reported that helping others was rewarding. Clearly, the youth’s perspectives on their development should be considered while creating prevention and promotion programs that foster internal and external assets.
- Open Access
- 1 December 2024
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 40 (S1) , S50
OD41 Conducting Systematic Reviews On Rare Diseases: Lessons Learned From The European Reference Networks Guidelines Programme
Introduction: A consortium of five Spanish health technology assessment (HTA) agencies conducted the European Reference Networks Guidelines Programme for the development, appraisal, and implementation of clinical practice guidelines aiming to support clinical decision-making in the field of rare diseases (RDs). In response to this objective, methodologists and information specialists conducted systematic reviews (SRs). This study aims to explore the barriers/facilitators they encountered.Methods: A survey was designed to elicit HTA agencies’ experience in developing SRs on RDs. Information was collected on the number of SRs conducted and the types of RDs and clinical questions addressed. In addition, they were asked to identify barriers and facilitators for each stage of the review (from the definition of PICO [population, intervention, comparator, outcome] components of the question to the issuing of recommendations). Finally, they were asked for process improvement suggestions. The survey was distributed by email and completed online. A thematic analysis was conducted to identify the issues identified at each stage of SR.Results: A total of 111 SRs were conducted on 35 RDs. Most clinical questions were about diagnosis and treatment. The main barriers identified were lack of MesH (Medical Subject Headings) terms associated with the conditions, non-representative abstracts and keywords, lack of relevant information in the body of the articles, and reported data not allowing for quantitative syntheses or recommendations to be made. Facilitating aspects included Orphanet’s specific source of RD documents and having expert clinicians in the working groups who were also involved in all steps of the SR.Conclusions: Conducting SRs in the field of RDs is challenging. Authors of primary studies are encouraged to be more exhaustive in reporting the results. More research focused on the SR methodology in RDs is necessary to address their particular characteristics and obtain robust results. It is crucial to collaborate with reference networks to address RDs, where the evidence is scarce.
- 1 December 2024
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 40 (S1) , S50
Open AccessOD41 Conducting Systematic Reviews On Rare Diseases: Lessons Learned From The European Reference Networks Guidelines Programme
Introduction: A consortium of five Spanish health technology assessment (HTA) agencies conducted the European Reference Networks Guidelines Programme for the development, appraisal, and implementation of clinical practice guidelines aiming to support clinical decision-making in the field of rare diseases (RDs). In response to this objective, methodologists and information specialists conducted systematic reviews (SRs). This study aims to explore the barriers/facilitators they encountered.Methods: A survey was designed to elicit HTA agencies’ experience in developing SRs on RDs. Information was collected on the number of SRs conducted and the types of RDs and clinical questions addressed. In addition, they were asked to identify barriers and facilitators for each stage of the review (from the definition of PICO [population, intervention, comparator, outcome] components of the question to the issuing of recommendations). Finally, they were asked for process improvement suggestions. The survey was distributed by email and completed online. A thematic analysis was conducted to identify the issues identified at each stage of SR.Results: A total of 111 SRs were conducted on 35 RDs. Most clinical questions were about diagnosis and treatment. The main barriers identified were lack of MesH (Medical Subject Headings) terms associated with the conditions, non-representative abstracts and keywords, lack of relevant information in the body of the articles, and reported data not allowing for quantitative syntheses or recommendations to be made. Facilitating aspects included Orphanet’s specific source of RD documents and having expert clinicians in the working groups who were also involved in all steps of the SR.Conclusions: Conducting SRs in the field of RDs is challenging. Authors of primary studies are encouraged to be more exhaustive in reporting the results. More research focused on the SR methodology in RDs is necessary to address their particular characteristics and obtain robust results. It is crucial to collaborate with reference networks to address RDs, where the evidence is scarce.
- Open Access
- 26 September 2023
- Published by Georg Thieme Verlag KG
- Vol. 17, Doc01
Evaluation of the safety, efficacy, effectiveness and cost-effectiveness of implantable Holter for prolonged monitoring in patients with previous stroke: a systematic review.
Atrial fibrillation (AF), which is associated with cryptogenic stroke, is the most common sustained arrhythmia in the general population. Because AF is asymptomatic and intermittent, its detection rate increases with the duration of monitoring. The objective of this study is to review the available evidence on the safety, efficacy, effectiveness and cost-effectiveness of AF diagnosis by prolonged monitoring with an implantable Holter monitor in adult patients with idiopathic or cryptogenic stroke of suspected cardioembolic origin, compared to conventional monitoring. Two independent reviewers performed a systematic review of the literature, identifying relevant studies through a structured search of Medline (Ovid), EMBASE, Web of Science and Cochrane Library and the databases of national and international health technology assessment agencies. The quality of the included studies was assessed with AGREE-II, AMSTAR-2 and CHEC. GRADE criteria were used to summarise the evidence. Four of the 211 papers identified were included: 1 clinical practice guideline, 2 systematic reviews, and 1 economic evaluation. The quality of the evidence reviewed was low. An implantable Holter monitor might be more effective in detecting AF than conventional monitoring. Serious adverse events were similar in both groups. The economic evaluation suggests that the technology is cost-effective. The available evidence suggests the diagnostic superiority of the implantable Holter monitor over the traditional Holter monitor. Due to the low quality of the evidence, further and higher quality studies on these technologies are needed before solid conclusions can be drawn.
- 26 September 2023
- Published by Georg Thieme Verlag KG
- Vol. 17, Doc01
Open AccessEvaluation of the safety, efficacy, effectiveness and cost-effectiveness of implantable Holter for prolonged monitoring in patients with previous stroke: a systematic review.
Atrial fibrillation (AF), which is associated with cryptogenic stroke, is the most common sustained arrhythmia in the general population. Because AF is asymptomatic and intermittent, its detection rate increases with the duration of monitoring. The objective of this study is to review the available evidence on the safety, efficacy, effectiveness and cost-effectiveness of AF diagnosis by prolonged monitoring with an implantable Holter monitor in adult patients with idiopathic or cryptogenic stroke of suspected cardioembolic origin, compared to conventional monitoring. Two independent reviewers performed a systematic review of the literature, identifying relevant studies through a structured search of Medline (Ovid), EMBASE, Web of Science and Cochrane Library and the databases of national and international health technology assessment agencies. The quality of the included studies was assessed with AGREE-II, AMSTAR-2 and CHEC. GRADE criteria were used to summarise the evidence. Four of the 211 papers identified were included: 1 clinical practice guideline, 2 systematic reviews, and 1 economic evaluation. The quality of the evidence reviewed was low. An implantable Holter monitor might be more effective in detecting AF than conventional monitoring. Serious adverse events were similar in both groups. The economic evaluation suggests that the technology is cost-effective. The available evidence suggests the diagnostic superiority of the implantable Holter monitor over the traditional Holter monitor. Due to the low quality of the evidence, further and higher quality studies on these technologies are needed before solid conclusions can be drawn.
- Open Access
- 11 September 2023
- Published by Wiley in European Journal of Neurology
- Vol. 30 (12) , 3928-3948
Systematic review of drug therapy for chorea in NXK2‐1‐related disorders: Efficacy and safety evidence from case studies and series
Background: The NKX2‐1‐related disorders (NKX2‐1‐RD) is a rare disorder characterized by choreiform movements along with respiratory and endocrine abnormalities. The European Reference Network of Rare Neurological Disorders funded by the European Commission conducted a systematic review to assess drug treatment of chorea in NKX2‐1‐RD, aiming to provide clinical recommendations for its management.Methods: A systematic pairwise review using various databases, including MEDLINE, Embase, Cochrane, CINAHL, and PsycInfo, was conducted. The review included patients diagnosed with chorea and NKX2‐1‐RD genetic diagnosis, drug therapy as intervention, no comparator, and outcomes of chorea improvement and adverse events. The methodological quality of the studies was assessed, and the study protocol was registered in PROSPERO.Results: Of the 1417 studies examined, 28 studies met the selection criteria, consisting of 68 patients. The studies reported 22 different treatments for chorea, including carbidopa/levodopa, tetrabenazine, clonazepam, methylphenidate, carbamazepine, topiramate, trihexyphenidyl, haloperidol, propranolol, risperidone, and valproate. No clinical improvements were observed with carbidopa/levodopa, tetrabenazine, or clonazepam, and various adverse effects were reported. However, most patients treated with methylphenidate experienced improvements in chorea and reported only a few negative effects. The quality of evidence was determined to be low.Conclusions: The management of chorea in individuals with NKX2‐1‐RD presents significant heterogeneity and lack of clarity. While the available evidence suggests that methylphenidate may be effective in improving chorea symptoms, the findings should be interpreted with caution due to the limitations of the studies reviewed. Nonetheless, more rigorous and comprehensive studies are necessary to provide sufficient evidence for clinical recommendations.
- 11 September 2023
- Published by Wiley in European Journal of Neurology
- Vol. 30 (12) , 3928-3948
Open AccessSystematic review of drug therapy for chorea in NXK2‐1‐related disorders: Efficacy and safety evidence from case studies and series
Background: The NKX2‐1‐related disorders (NKX2‐1‐RD) is a rare disorder characterized by choreiform movements along with respiratory and endocrine abnormalities. The European Reference Network of Rare Neurological Disorders funded by the European Commission conducted a systematic review to assess drug treatment of chorea in NKX2‐1‐RD, aiming to provide clinical recommendations for its management.Methods: A systematic pairwise review using various databases, including MEDLINE, Embase, Cochrane, CINAHL, and PsycInfo, was conducted. The review included patients diagnosed with chorea and NKX2‐1‐RD genetic diagnosis, drug therapy as intervention, no comparator, and outcomes of chorea improvement and adverse events. The methodological quality of the studies was assessed, and the study protocol was registered in PROSPERO.Results: Of the 1417 studies examined, 28 studies met the selection criteria, consisting of 68 patients. The studies reported 22 different treatments for chorea, including carbidopa/levodopa, tetrabenazine, clonazepam, methylphenidate, carbamazepine, topiramate, trihexyphenidyl, haloperidol, propranolol, risperidone, and valproate. No clinical improvements were observed with carbidopa/levodopa, tetrabenazine, or clonazepam, and various adverse effects were reported. However, most patients treated with methylphenidate experienced improvements in chorea and reported only a few negative effects. The quality of evidence was determined to be low.Conclusions: The management of chorea in individuals with NKX2‐1‐RD presents significant heterogeneity and lack of clarity. While the available evidence suggests that methylphenidate may be effective in improving chorea symptoms, the findings should be interpreted with caution due to the limitations of the studies reviewed. Nonetheless, more rigorous and comprehensive studies are necessary to provide sufficient evidence for clinical recommendations.
- Open Access
- 9 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281573
Exploring the values, preferences, and information needs of patients with NKX2-1-related disorders: A qualitative study protocol
Background: NKX2-1-related disorders have a prevalence of 1:500,000 and are therefore considered a rare condition according to the European Commission’s definition. The European Reference Network of Rare Neurological Disorders is developing the first clinical practice guideline on the management of this condition, with the support of the Andalusian Health Technology Assessment Area, Endo-ERN, ERN-Lung and Imegen, within the framework of the ERNs Guidelines programme (DG SANTE/2018/B3/030). Within the scope of this programme, it becomes necessary to explore the patient perspective in order to include it in the ongoing clinical practice guideline and accompanying patient information booklet. Methods and analysis: This study will use qualitative methods to explore the values, preferences and information needs of patient with NKX2-1-related disorders and their caregivers. Participants will come from a variety of countries throughout Europe. One focus group and four semi-structured interviews will be conducted. Pairs will analyse the data using Grounded Theory. The Andalusian Regional Ministry of Health’s Ethics Coordinating Committee for Biomedical Research (Sevilla, Andalucía, Spain) has approved this study protocol (29/03/2022). Discussion: This is the first study to explore the values, preferences, and information needs of patients with NKX2-1-related disorders. The proposed study’s findings will contribute to the generation of useful knowledge that will provide guidance to improve the care given to patients with the studied condition. While this study will provide valuable insights into the perspectives of patients with NKX2-1-related disorders, the findings are unlikely to be generalizable to patients with other conditions.
- 9 February 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (2) , e0281573
Open AccessExploring the values, preferences, and information needs of patients with NKX2-1-related disorders: A qualitative study protocol
Background: NKX2-1-related disorders have a prevalence of 1:500,000 and are therefore considered a rare condition according to the European Commission’s definition. The European Reference Network of Rare Neurological Disorders is developing the first clinical practice guideline on the management of this condition, with the support of the Andalusian Health Technology Assessment Area, Endo-ERN, ERN-Lung and Imegen, within the framework of the ERNs Guidelines programme (DG SANTE/2018/B3/030). Within the scope of this programme, it becomes necessary to explore the patient perspective in order to include it in the ongoing clinical practice guideline and accompanying patient information booklet. Methods and analysis: This study will use qualitative methods to explore the values, preferences and information needs of patient with NKX2-1-related disorders and their caregivers. Participants will come from a variety of countries throughout Europe. One focus group and four semi-structured interviews will be conducted. Pairs will analyse the data using Grounded Theory. The Andalusian Regional Ministry of Health’s Ethics Coordinating Committee for Biomedical Research (Sevilla, Andalucía, Spain) has approved this study protocol (29/03/2022). Discussion: This is the first study to explore the values, preferences, and information needs of patients with NKX2-1-related disorders. The proposed study’s findings will contribute to the generation of useful knowledge that will provide guidance to improve the care given to patients with the studied condition. While this study will provide valuable insights into the perspectives of patients with NKX2-1-related disorders, the findings are unlikely to be generalizable to patients with other conditions.
- 8 March 2022
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52 (6) , 1001-1013
Effectiveness of psychological interventions in preventing postpartum depression in non-depressed women: a systematic review and meta-analysis of randomized controlled trials
Postpartum depression (PPD) is one of the most common disorders following childbirth. This systematic review and meta-analysis (SR/MA) aimed to assess the effectiveness of psychological interventions in preventing PPD in non-depressed women. PRISMA guidelines were followed. MEDLINE (Ovid and PubMed), PsycINFO, Web of Science, Scopus, CINAHL, CENTRAL, OpenGrey, Australian New Zealand Clinical Trial Registry and clinicaltrial.gov were searched. Randomized controlled trials (RCTs) conducted with pregnant or postpartum (up to 12 months) women who were non-depressed at baseline were selected. The outcomes were the incidence of PPD and/or the reduction of postpartum depressive symptoms. The standardized mean difference (SMD) using random-effect models was calculated. Sensitivity, sub-group and meta-regression analyses were performed. 17 RCTs were included in the SR and 15 in the MA, representing 4958 participants from four continents. The pooled SMD was −0.175 [95% confidence interval (CI) −0.266 to −0.083;p< 0.001] and sensitivity analyses confirmed the robustness of this result. Heterogeneity was low (I2 = 21.20%) and was fully explained by a meta-regression model including one variable (previous deliveries). The meta-regression model and MA stratified by previous deliveries indicated that interventions focused on primiparous women are more effective. There was no evidence of publication bias. Few RCTs had an overall low risk of bias. According to GRADE, the quality of evidence was moderate. Psychological interventions have very little effectiveness in preventing PPD in non-depressed women, although this effectiveness is greater in interventions focused on primiparous women. Further RCTs with a low risk of bias and more effective interventions are needed.
- 8 March 2022
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52 (6) , 1001-1013
Effectiveness of psychological interventions in preventing postpartum depression in non-depressed women: a systematic review and meta-analysis of randomized controlled trials
Postpartum depression (PPD) is one of the most common disorders following childbirth. This systematic review and meta-analysis (SR/MA) aimed to assess the effectiveness of psychological interventions in preventing PPD in non-depressed women. PRISMA guidelines were followed. MEDLINE (Ovid and PubMed), PsycINFO, Web of Science, Scopus, CINAHL, CENTRAL, OpenGrey, Australian New Zealand Clinical Trial Registry and clinicaltrial.gov were searched. Randomized controlled trials (RCTs) conducted with pregnant or postpartum (up to 12 months) women who were non-depressed at baseline were selected. The outcomes were the incidence of PPD and/or the reduction of postpartum depressive symptoms. The standardized mean difference (SMD) using random-effect models was calculated. Sensitivity, sub-group and meta-regression analyses were performed. 17 RCTs were included in the SR and 15 in the MA, representing 4958 participants from four continents. The pooled SMD was −0.175 [95% confidence interval (CI) −0.266 to −0.083;p< 0.001] and sensitivity analyses confirmed the robustness of this result. Heterogeneity was low (I2 = 21.20%) and was fully explained by a meta-regression model including one variable (previous deliveries). The meta-regression model and MA stratified by previous deliveries indicated that interventions focused on primiparous women are more effective. There was no evidence of publication bias. Few RCTs had an overall low risk of bias. According to GRADE, the quality of evidence was moderate. Psychological interventions have very little effectiveness in preventing PPD in non-depressed women, although this effectiveness is greater in interventions focused on primiparous women. Further RCTs with a low risk of bias and more effective interventions are needed.
- 1 January 2022
- Published by AETSA - Fundacion Publica Andaluza Progreso y Salud M.P.
Holter implantable con tecnología link -online- para monitorización cardiaca prolongada en pacientes con ictus previo
Introducción / justificación. El Holter implantable con tecnología link -online- de monitorización cardiaca prolongada para la detección de arritmias (ILR) es un dispositivo subcutáneo para el diagnóstico de arritmias cardiacas, fundamentalmente de fibrilación auricular (FA), en pacientes de ictus cardioembólico idiopático. El objetivo de esta tecnología es la búsqueda de la etiología del ictus en el paciente. Objetivo. Evaluar la evidencia disponible en cuanto a la seguridad, eficacia (validez diagnóstica y precisión) y efectividad (utilidad clínica) del diagnóstico de la fibrilación auricular a través de la monitorización con Holter implantable con tecnología link-online- en pacientes adultos con ictus cardioembólico idiopático o criptogénico con sospecha de origen cardioembólico, en comparación con el holter convencional (monitorización no invasiva de 24 horas). Método. Se realizó una revisión sistemática. Los estudios fueron identificados, hasta marzo de 2021, a través de las bases de datos referenciales Medline (Ovid), EMBASE, Web of Science, Cochrane Library y Centre for Reviews and Dissemination; así como se realizó una búsqueda manual en las bases de datos de las principales agencias de evaluación de tecnologías sanitaras nacionales e internacionales. La selección, extracción de datos, evaluación de los sesgos, aplicabilidad y calidad, así como la síntesis de evidencia, se realizaron por pares. Resultados. 199 documentos fueron identificados, tras eliminar los textos duplicados, 179 estudios fueron evaluados a título y resumen y 28 a texto completo, de los cuales 5 fueron finalmente incluidos (dos estudios primarios, dos revisiones sistemáticas y una guía de práctica clínica). La evidencia muestra que el holter implantable con tecnología link-online- puede ser utilizado para identificar la fibrilación auricular después de un accidente cardiovascular criptogénico. Se necesita ampliar la evidencia y la calidad metodológica de los estudios sobre la tecnología para establecer conclusiones robustas.
- 1 January 2022
- Published by AETSA - Fundacion Publica Andaluza Progreso y Salud M.P.
Holter implantable con tecnología link -online- para monitorización cardiaca prolongada en pacientes con ictus previo
Introducción / justificación. El Holter implantable con tecnología link -online- de monitorización cardiaca prolongada para la detección de arritmias (ILR) es un dispositivo subcutáneo para el diagnóstico de arritmias cardiacas, fundamentalmente de fibrilación auricular (FA), en pacientes de ictus cardioembólico idiopático. El objetivo de esta tecnología es la búsqueda de la etiología del ictus en el paciente. Objetivo. Evaluar la evidencia disponible en cuanto a la seguridad, eficacia (validez diagnóstica y precisión) y efectividad (utilidad clínica) del diagnóstico de la fibrilación auricular a través de la monitorización con Holter implantable con tecnología link-online- en pacientes adultos con ictus cardioembólico idiopático o criptogénico con sospecha de origen cardioembólico, en comparación con el holter convencional (monitorización no invasiva de 24 horas). Método. Se realizó una revisión sistemática. Los estudios fueron identificados, hasta marzo de 2021, a través de las bases de datos referenciales Medline (Ovid), EMBASE, Web of Science, Cochrane Library y Centre for Reviews and Dissemination; así como se realizó una búsqueda manual en las bases de datos de las principales agencias de evaluación de tecnologías sanitaras nacionales e internacionales. La selección, extracción de datos, evaluación de los sesgos, aplicabilidad y calidad, así como la síntesis de evidencia, se realizaron por pares. Resultados. 199 documentos fueron identificados, tras eliminar los textos duplicados, 179 estudios fueron evaluados a título y resumen y 28 a texto completo, de los cuales 5 fueron finalmente incluidos (dos estudios primarios, dos revisiones sistemáticas y una guía de práctica clínica). La evidencia muestra que el holter implantable con tecnología link-online- puede ser utilizado para identificar la fibrilación auricular después de un accidente cardiovascular criptogénico. Se necesita ampliar la evidencia y la calidad metodológica de los estudios sobre la tecnología para establecer conclusiones robustas.